About
Bio
FDAnews.com covers domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration, including four newsletters: Drug GMP Report, Drug Industry Daily, International Devices & Diagnostics Monitor and The GMP Letter.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United States of America
Frequency
upgrade
Circulation
upgrade
Sectors
Government Agencies, Pharmaceutical Manufacturers, Pharmacies
Bio
FDAnews.com covers domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration, including four newsletters: Drug GMP Report, Drug Industry Daily, International Devices & Diagnostics Monitor and The GMP Letter.
Website
Social media
Location
Frequency
Circulation
Sectors
Government Agencies, Pharmaceutical Manufacturers, Pharmacies
Most recent articles by FDAnews.com
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to FDAnews.com
-
National Review
Designed as a journal of conservative opinion. Covers the national and international developments related to conservative action and reports and analyzes on what various conservatives are saying, thinking and doing. Committed to providing important, expert analyses of the day’s hottest stories and to breaking those stories in a manner consistent with the publication's worldview.
ViewThomson Reuters FoundationBackground and Format The Thomson Reuters Foundation, the charitable arm of Thomson Reuters, covers the world’s under-reported stories, with a global team of about 40 staff journalists on humanitarian crises, women’s empowerment, the human impact of climate change, property rights, and trafficking and slavery. All of its stories are published on its news website, news.trust.org, as well as distributed on the Reuters news wire. Established in 1983 as a training programme for journalists in developing countries, the Thomson Reuters Foundation promotes free, independent journalism through its continued training programmes and also acts to promote socio-economic progress worldwide. As well as its news service and journalism training, the Foundation runs Trust Law - which connects law firms providing pro bono work to NGOs and social enterprises - and holds the annual Trust Women conference focused on empowering women and combating trafficking and slavery. Trust.org is the Foundation’s main website. Audience and Readership: People interested in humanitarian stories as well as campaigners and lawyers along with people working in law enforcement, politics and global business. Deadline: Best to contact in the morning. Frequency: Daily - online. Monthly Unique Users: This figure is not available. Distribution: Content is produced for the website and also distributed through the Reuters news wire. Awards: 2013 - Online Media Awards, Best National/World News Site: for Aswat Masriya (nominated) Other Information: The Foundation hold an annual conference called Trust Women which brings together campaigners, filmmakers, lawyers, senior figures from law enforcement, politics, the judiciary and global business to take action to advance the status of women and their rights. PRs can get involved by sending us ideas for speakers - individuals who are leaders in their field – to media.foundation@thomsonreuters.com. It also provides the TrustLaw global pro bono legal programme connecting NGOs and social entrepreneurs with big law firms. They like to receive new ideas from PRs and quirky stories. Embargoed content is preferable - or to at least receive a story well ahead of time. They're particularly interested in 'people stories', a story that has a human face. Whatever they receive, it must fit into their remit, content has to have a global view and focus on under reported stories, humanitarian relief, governance, trafficking and slavery, and must promote socio-economic progress. The team are also available to moderate at presentations and conferences if it can promote the Foundation.
ViewPink SheetWritten for executives and administrators in the pharmaceutical and biotechnology industries. Highlights all aspects of the pharmaceutical industry, including marketing, research and development and regulatory and legislative issues. Regular features include regulatory news, drug approvals, FDA advisory committee meetings, enforcement reports, business and marketing news, financial news and managed care developments.
ViewGovernment TechnologyProvides state and local government executives with the knowledge necessary to implement and shape IT solutions for their agency or department. Editorial offers information on viable solutions and applications, the role of technology in the modern government and interviews with authors, elected officials, industry experts and academicians. Also includes case studies and success stories by agencies and departments who are applying technology to improve services to citizens around the world, along with news on the latest developments in legislation and technology. Technology coverage includes electronic data processing, desktop systems, SSL (Secure Socket Layer), mainframes and geographic information systems (GIS). Editorial focuses exclusively on the technology issues, applications, products and services that are essential to government business, specifically looking at how technology works. Regular departments include: Local Government; eGovernment; Product News; Tech Focus; Point of View; Justice; Privacy; CIO Profile; Procurement; and Geo Info. Government Technology DOES accept bylined articles/submissions. Government Technology magazine publishes material from staff writers, freelancers, end-users, government managers and executives and corporate communications writers. They are interested in information technology applications (case studies) for state and local government.
ViewFiercePharmaAimed a senior pharmaceutical industry executives, project managers and other business decision makers at pharmaceutical and related life sciences companies, FiercePharma provides daily insider news from the post-approval world including manufacturing, labeling, post-marketing issues and other pharmaceutical industry business topics with a special focus on pharmaceutical company news and the market development of FDA approved products. It includes additional coverage on specific topics such as the changing landscape of generic drugs, pharmaceutical sales and marketing news and manufacturing issues. FiercePharma DOES accept bylined articles/submissions. Contact the editor. The newsletter claims over 150,000 subscribers.
ViewUse CisionOne to find more relevant outletsExplore journalists that write for FDAnews.com
Contact us to find more relevant journalistsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.